← Leaderboards
Farrah Jasmine Mateen
Massachusetts General Hospital
$1,456,315
Attributed
$1,456,315
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $498.5K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,456,315 · 3
By mechanism
R21$1,084,008 · 2
RF1$372,307 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Michael Levy$4,359,862
- Charles A Hales$9,896,268
- Vicki Fung$9,811,100
- James B Meigs$19,655,119
- Susan L. Santangelo$11,746,639
Others in their field
Other Emerging Leaders on “Cost”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Scott Topper · Broad Institute, Inc.$77,958,806
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Mark Marino · Venturewell$48,913,644
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,367,817
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
Research focus
CostResearch PersonnelCountryFutureEnrollmentEpidemiologyTrainingIncomeNeurologistResearch MethodologyPharmaceutical PreparationsRandomizedAfricanReportingMethodologyLow Income CountryHealth PersonnelClinical TrialsHospitalsDisabilityMedicalMedicineHuman ResourcesParticipant
Grant awards (7)
Capacity Building for the Diagnosis and Treatment of Neuromyelitis Optica using Point of Care Aquaporin-4 Antibody Testing$372,306
RF1 · FY2025 · TW · contact PI
Capacity Building for the Diagnosis and Treatment of Neuromyelitis Optica using Point of Care Aquaporin-4 Antibody Testing$1
RF1 · FY2025 · TW · contact PI
MAMBO: Measuring Ambulation, Motor, and Behavioral Outcomes with post-stroke Fluoxetine in Tanzania$326,408
R21 · FY2019 · TW · contact PI
MAMBO: Measuring Ambulation, Motor, and Behavioral Outcomes with post-stroke Fluoxetine in Tanzania$172,056
R21 · FY2019 · TW · contact PI
CLINICAL UTILITY OF A SMARTPHONE-BASED EEG SYSTEM FOR PEOPLE WITH EPILEPSY IN BHUTAN$194,630
R21 · FY2018 · NS · contact PI
MAMBO: Measuring Ambulation, Motor, and Behavioral Outcomes with post-stroke Fluoxetine in Tanzania$189,181
R21 · FY2018 · TW · contact PI
CLINICAL UTILITY OF A SMARTPHONE-BASED EEG SYSTEM FOR PEOPLE WITH EPILEPSY IN BHUTAN$201,733
R21 · FY2017 · NS · contact PI